A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic Stroke
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of Tanakan® 240mg in association
with Acetylsalicylic acid (325mg/day) in the recovery of neurological impairment following
ischemic stroke.